This animal experiment revealed that fucoidan reduces body weight gain, epididymal fat mass, plasma triglyceride, and liver steatosis, which are accompanied by the down-regulation of the mRNA expression of PPARγ, adipose-specific fatty acid-binding protein, and acetyl CoA carboxylase in adipose tissue. Here, GOT2 is linked to fatty liver disease.